While in biofilms bacteria are embedded into an extracellular matrix which forms 17 inaccessible barrier for antimicrobials thereby drastically increasing the concentrations 18 of antibiotics required for treatment. Here we show that the susceptibility of S. aureus 19 and P. aeruginosa to antibiotics in mixed biofilms significantly differs from monoculture 20 biofilms depending on both conditions and chosen antimicrobial agents. While S. aureus 21 could completely avoid vancomycin, ampicillin and ceftriaxone by embedding into the 22 biofilm of P. aeruginosa, the very same consortium was characterized by 10-fold 23 increase in susceptibility to broad-spectrum antimicrobials like ciprofloxacin and 24 aminoglycosides compared to monocultures. These data clearly indicate that efficient 25 treatment of biofilm-associated mixed infections requires antimicrobials active against 26 both pathogens, since the interbacterial antagonism would enhance the efficacy of 27 treatment. Moreover, similar increase in antibiotics efficacy was observed when 28 P. aeruginosa suspension was added to the mature S. aureus biofilm, compared to 29 S. aureus monoculture, and vice versa. These findings open promising perspectives to 30 increase the antimicrobial treatment efficacy of the wounds infected with nosocomial 31 pathogens by the transplantation of the skin residential microflora.
Introduction
Bacterial fouling is an important factor that strongly affects acute and chronic wounds 34 healing and prevents wound scratch closure 1 . Besides the physical obstruction of the cells, 35 pathogenic bacteria produce various virulence factors including toxins and proteases that also 36 affect cytokine production by keratinocytes, induce apoptosis of the host cells and cause 37 inflammation 2-6 . 38 S. aureus and P. aeruginosa are one of the most widespread pathogens causing various 39 nosocomial infections, including pneumonia on the cystic fibrosis background, healthcare 40 associated pneumonia and chronic wounds 7-10 . During infection, bacterial cells are embedded 41 into a self-produced extracellular matrix of organic polymers this way forming either mono-or In the last decades different approaches to inhibit the biofilm formation by various bacteria 150 were developed 55, 56, 58 , appearing nowadays more successful in prevention of S. aureus biofilm 151 formation 61, 62, 64 . Therefore we simulated the S. aureus -P. aeruginosa mixed biofilm formation 152 under the conditions of biofilm-preventing treatment. For that, bacteria were cultivated in the 153 presence of a derivative of 2(5H)-furanone denoted as F105, identified in recent study as an 154 efficient inhibitor of biofilm formation by S. aureus 73, 75 , while exhibiting no significant effect 155 against P. aeruginosa (Table S1 ). When S. aureus was grown for 48 h in the presence of 2.5 156 µg/ml of F105, no biofilm was formed and cells growth was retarded, while most of the cells Table S1 ). Moreover, the biofilm formation was slightly increased as is produced mainly by P. aeruginosa. Next, in marked contrast to the control, the S. aureus cells 171 were observed predominantly in the middle layers of the biofilm (compare Fig. 2 E and K) . 172 The microscopic data were also validated by direct CFU counting in the biofilm; by using 173 mannitol salt agar plates and cetrimide agar plates the bacterial species were differentiated and 174 their CFUs were counted separately ( Fig. S2 ). In the presence of F105 the amount of adherent 175 viable S. aureus cells decreased by six orders of magnitude in monoculture, suggesting complete 176 inhibition of the biofilm formation, while no significant differences in CFUs of P. aeruginosa 177 could be observed. In a mixed biofilm, the S. aureus to P. aeruginosa ratio remained unchanged 178 in the control, while the fraction of viable S. aureus cells decreased slightly in the presence of 179 F105, this way confirming CLSM data and supporting the hypothesis that S. aureus is apparently 180 able to embed and hide thereby in the biofilm formed by P. aeruginosa when its own biofilm 181 formation is repressed.
183
Atomic force microscopy 184 The atomic force microscopy of both monocultures and mixed biofilms of S. aureus -185 P. aeruginosa confirmed the CLSM data. Thus, in control wells the biofilms of monocultures of 186 both strains formed a typical confluent multilayer biofilm ( Fig. 3 A, B ), in mixed biofilm 187 S. aureus was prevalently distributed in the upper layers ( Fig. 3 C) . Interestingly, the adhesion 188 force of the mixed biofilm was 3-fold lower compared to S. aureus monoculture biofilm and 2-189 fold lower compared to P. aeruginosa monoculture biofilm ( Fig. 4 ), suggesting more irregular 190 structure of the mixed biofilm 53 . When growing with F105, only P. aeruginosa could be 191 observed on the biofilm surface in the mixed culture, suggesting that S. aureus was hidden into 192 the lower biofilm layers. Since the adhesion force of the mixed biofilm in the presence of F105 193 was similar to that one in the monoculture P. aeruginosa ( Fig. 3 F and Fig. 4 ), we assumed that 194 the biofilm matrix under these conditions was presumably formed by P. aeruginosa. S. aureus and P. aeruginosa susceptibility to antibiotics in mixed biofilms 209 Our data suggest that S. aureus under anti-biofilm treatment conditions is able to form 210 microcolonies in the biofilm of P. aeruginosa, thereby apparently changing their susceptibility to 211 antimicrobials. To further verify this assumption, the effect of various conventional antibiotics 212 on preformed mono-and polymicrobial biofilms was studied. The 48-h old monoculture and 213 mixed biofilms were prepared in 24-well adhesive plates in either absence or presence of F105 to 214 repress the biofilm formation by S. aureus itself. Then the biofilms were washed with sterile 215 0.9% NaCl and wells were loaded with fresh broth supplemented with antibiotics at wide range 216 of final concentrations to fill the range of their 1-16 fold MBCs (see table S1 for MBC values). 217 After 24h incubation the amount of CFUs of both S. aureus and P. aeruginosa in both the culture 218 liquid and the biofilm was determined by the drop plate assay and the distribution of cells in the 219 mixed biofilm was assessed by CLSM. 220 First, the biofilm-eradicating activity was investigated for the antibiotics conventionally 221 used for S. aureus treatment but typically inefficient against P. aeruginosa including 222 vancomycin, tetracycline, ampicillin and ceftriaxone (Figs 5, S6, S7). In monoculture, 223 vancomycin reduced the amount of viable S. aureus cells in the biofilm by 3 orders of magnitude 224 only at 16×MBC ( Fig. 5 A) . In the culture liquid, 0.125×MBC (corresponds to 1×MIC, see Table   225 S1) of vancomycin was sufficient to decrease of CFUs count by three orders of magnitude ( Next, we investigated the effect of broad-spectrum antimicrobials such as ciprofloxacin, 298 amikacin and gentamycin which are active against both S. aureus and P. aeruginosa (see Table   299 S1). In contrast to the previous group of antimicrobials, high concentrations of ciprofloxacin 300 11 efficiently eradicated both P. aeruginosa and S. aureus monocultures even in the biofilm-301 embedded form ( Fig. 7 A, B) . Interestingly, when the mixed biofilm was treated, nearly 10-fold 302 lower concentration of antimicrobial was sufficient to obtain similar reduction of P. aeruginosa 303 CFUs in the biofilm, although not for detached cells (Fig 7 B, Fig S11) . Moreover, significant 304 increase of susceptibility of both biofilm-embedded and detached S.aureus to ciprofloxacin was 305 observed in mixed culture in contrast to monoculture (see Figs 7A, S11 A). Finally, in the mixed 306 biofilm the complete death of both P. aeruginosa and S. aureus could be observed at 8×MBC of 307 ciprofloxacin, in marked contrast to monocultures (Fig 7 A, B) . Figs. 7, 8, S11, S12) . Surprisingly, the efficiency of aminoglycosides against S. aureus in 331 mixed culture did not depend on presence of F105 (pallets C in Figs. 7, 8 , S11, S12).
333
The CLSM analysis of S. aureus and P. aeruginosa monoculture and mixed biofilms 334 treated with ciprofloxacin confirmed the CFUs counting data. In particular, while 8×MBC did 335 not affect either S. aureus or P. aeruginosa cells in monoculture biofilms ( Fig. 7 E, F) , in the 336 12 mixed biofilm a huge fraction of non-viable cells was observed ( Fig. 7 G) . In marked contrast, 337 repression of the S. aureus biofilm production by F105 led to a reversal with most P. aeruginosa 338 cells green-stained while S. aureus identified as non-viable in mixed culture (Fig. 7 J) . S. aureus in the bottom layers irrespective of its biofilm repression by F105 ( Fig. S14 , cells 356 distribution patterns) but qualitatively similar bacterial survival patterns (see Fig. S12 ). 357 Moreover, under single antibiotic treatment P. aeruginosa were presumably dead, while 358 S. aureus remained viable (Fig. S14 ). In the presence of F105 P. aeruginosa remained alive and 359 much less S. aureus cells could be observed in the biofilm, as almost all of them were identified 360 as non-viable. 361 Taken together these data suggest that complex interspecies interactions between S. aureus the SCVs constituted up to 90% of S. aureus population (Fig. S15 ), that fits with previous 381 reports 27 , the effect of higher efficiency of broad-spectrum antibiotics against mixed biofilms 382 could nevertheless be observed (Fig. S15) . 383 This fact together with the observation that the repression of S. aureus by F105 abrogated 384 the effect of higher efficiency of aminoglycosides against P. aeruginosa in mixed biofilms 385 indicates that the increase of broad-spectrum antibiotics efficacy against P. aeruginosa and 386 S. aureus in mixed biofilms is less related or unrelated to SCV formation and rather governed by 387 interspecies interaction between these bacteria. One of the main antagonistic tools of 388 P. aeruginosa is the production of cyanide 77 . To test whether it could be one of mechanisms 389 increasing the efficiency of antimicrobials in mixed cultures, the experiments have been 390 14 performed by using S.aureus 0349 pCXcydAB sa 77 strain insensitive to cyanide. Despite of 391 cyanide resistance, similar drastic reduction of S. aureus CFU in mixed biofilms could be 392 observed when treated with ciprofloxacin and aminoglycosides also ruling out the cyanide 393 synthesis by P. aeruginosa as the key contributing mechanism and indicating that other factors 394 lead the observed effects (Fig. S16 ).
396
Intervention of P. aeruginosa into S. aureus biofilm and vice versa as a 397 possible way to enhance antimicrobial susceptibility 398 Our results indicate that under appropriate conditions both S. aureus and P. aeruginosa due 399 to their antagonistic interactions appear more susceptible to broad-spectrum antimicrobials in 400 polymicrobial biofilms, compared to their monoculture counterparts. Based on these data, we 401 have suggested that also the susceptibility of monoculture biofilms could be increased by 402 deliberate intervention of P. aeruginosa into preformed S. aureus biofilm, and vice versa. 403 To verify the efficacy of this approach, P. aeruginosa suspension (10 6 CFU/mL) was 404 added to the 24 h-old S. aureus biofilm and bacteria were incubated for the next 24 h. Then the 405 biofilm was washed by sterile saline and fresh broth containing different antimicrobials was 406 added into the wells. After 24 h the number of P. aeruginosa and S. aureus CFUs was counted 407 by using differential media.
408
The introduction of P. aeruginosa into S. aureus biofilm did not change the efficacy of any 409 antibiotic against P. aeruginosa itself (Fig. 10, lane II) . In contrast, 1×MBC of ciprofloxacin led 410 to the reduction of viable S. aureus in biofilm by 3 orders of magnitude, while in the 411 monoculture 4-8×MBC was required to achieve the same effect (Fig. 10, interspecies interactions that likely overwhelm the potential benefits from biofilm protection. 437 Here we show that in S. aureus -P. aeruginosa mixed biofilms, the most common pathogenic 438 agents causing various nosocomial infections 7-9 , bacterial susceptibility to antibiotics is 439 drastically changed making them significantly more or less vulnerable to treatment than in 440 monoculture biofilms depending on both conditions and chosen antimicrobial agents. 441 Despite of the antagonistic relationship between S. aureus and P. aeruginosa described in 442 multiple studies 34, 35, 80 , these bacteria can be found in close association in acute and chronic 443 wounds being embedded into mixed biofilms 8, [38] [39] [40] [41] [42] . Our in vitro data show that the inoculation of 444 S. aureus to the mature P. aeruginosa biofilm or vice versa leads to the formation of mixed 445 biofilm, although with the prevalence of the first biofilm former (Fig. 1) . The co-cultivation of 446 both bacteria results in the formation of a more rigid biofilm, where S. aureus is located mainly 447 in the upper layers, while P. aeruginosa can be found mostly in the lower layers of the biofilm 448 ( Fig. 2) , in agreement with earlier data 15,42-45 . 449 In several works the alteration of S. aureus susceptibility to various antimicrobials in 450 presence of P. aeruginosa has been shown mainly in liquid cultures 21, 81, 82 . Here, we investigated 451 the effect of two groups of antimicrobials on bacterial viability in mixed biofilms. S11, S12 reds on panels A and C). In addition, ciprofloxacin, gentamicin and amikacin at 462 8×MBCs significantly reduced the number of CFUs of biofilm-embedded P. aeruginosa (Figs 5, 463 7, 8, S6, S7, S11, S12 blues on panels B and D). and cyanide production by P. aeruginosa (see Figs S15, S16). Apparently, this effect could be 491 attributed to rhamnolipids synthesis with P. aeruginosa which increase S. aureus susceptibility 492 to aminoglycosides 81 . 493 In contrast to other works on antimicrobial susceptibility of S. aureus -P. aeruginosa dual 494 species cultures, here we show that S. aureus also affects the susceptibility of P. aeruginosa 495 biofilm-embedded cells to antimicrobials with the most pronounced effect for aminoglycosides. 496 Moreover, tetracycline and ceftriaxone, while being inefficient against P. aeruginosa, at high 497 concentrations significantly reduced the CFUs of this bacterium in the mixed biofilms (Fig. S7) . 498 This suggests that mechanisms of interbacterial interaction affecting bacterial susceptibility in 499 biofilms differ from those in liquid cultures and are still to be understood. attributed to either the significant reduction of S. aureus fraction in the biofilm (see Fig. 9 , S13, 505 S14) or the repression of the antagonistic factors production by S. aureus due to complex 506 changes in its cell metabolism in the presence of F105 73,75 . Nevertheless, the molecular basis of 507 these complex interbacterial interactions that under certain conditions lead to a clear reversal in 508 the antimicrobials susceptibility requires further investigations. 509 Taken together, our data clearly indicate that efficient treatment of biofilm-associated 510 mixed infections requires antimicrobials which would be active against dominant pathogens. As 511 we have shown for the S. aureus and P. aeruginosa mixed culture model, in this case the 512 interbacterial antagonism under certain conditions assists antimicrobial treatment. In contrast, 513 treatment by antibiotics with different efficacy against various consortia members leads to the 514 survival of sensitive cells in the matrix formed by the resistant ones. 515 Finally, we have shown that S. aureus and P. aeruginosa are able to penetrate into each 516 other's mature biofilms (see Fig. 1 A and B ) and by this intervention significantly affect the 517 susceptibility of the mixed biofilm to antimicrobials (Fig. 10 ). When P. aeruginosa was 518 introduced into S. aureus biofilm, all antimicrobials reduced the amount of CFUs of both 519 bacteria in the biofilm by 3 orders of magnitude at 1-2×MBC with more pronounced effect 520 observed for gentamicin. In the reverse experiment, the inoculation of S. aureus to the mature 521 P. aeruginosa biofilm significantly increased the efficacy of ciprofloxacin against P. aeruginosa.
522
From a broader perspective, we believe that artificial intervention of antagonistic bacteria 523 into already preformed monoculture biofilms could be used to enhance their antimicrobial 524 treatment efficacy. We suggest that this approach has a strong potential of further development 525 towards innovative treatment of biofilm-associated infections such as introduction of the skin 526 residential saprophytic microflora to the biofilms formed by nosocomial pathogens to increase 527 antimicrobial treatment efficacy. While in this work we demonstrated the synergy of 528 interbacterial antagonism with antimicrobials using the well-studied S. aureus -P. aeruginosa 529 model system, we believe that many other bacteria of normal body microflora are available to 530 antagonize with nosocomial pathogens and thus can be used for the enhancement of microbial 531 infections treatment by using microbial transplantation. 
